PROPANC BIOPHARMA, INC. : conclusion of a material definitive agreement, creation of a direct financial obligation or obligation under an off-balance sheet arrangement of a holder, financial statements and supporting documents (form 8-K)

Lance Gravel
Promissory Note
Item 1.01 Conclusion of a Material Definitive Agreement. At January 4, 2022, Propanc Biopharma, Inc. (the “Company”) has entered into a securities purchase agreement (the “Purchase Agreement”) with Sixth Stre...